Considering the bihormonal nature of the pathophysiology of diabetes, the glucose-dependent insulinotropic and glucagonostatic properties of GLP-1 have made GLP-1 an ideal candidate for the treatment of T1DM and T2DM. This evidence concerns the gene GCG and type 2 diabetes mellitus.